'We don't see' weight-loss drugs impacting medical devices' sales, says Abbott CEO Robert Ford

Robert Ford, Abbott chairman and CEO, joins 'Closing Bell Overtime' to talk Q3 earnings, the impact of weight loss drugs on their product and more.